Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | P4HB | P07237 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30269173 | 0.80 | TERT (0.40) | SLC1A2SMN1; SMN2TSHRHTTL3MBTL1 | |
| SCHEMBL17841877 | 0.80 | TERT (0.40) | SLC1A2SMN1; SMN2TSHRHTTL3MBTL1 | |
| SCHEMBL12107712 | 0.79 | SLC1A2 (0.40) | SLC1A2SMN1; SMN2TSHRHTTL3MBTL1 | |
| SCHEMBL16652232 | 0.79 | TSHR (0.44) | SLC1A2SMN1; SMN2TSHRHTTL3MBTL1 | |
| SCHEMBL10037954 | 0.77 | SLC1A2 (0.34) | SLC1A2SMN1; SMN2TSHRHTTL3MBTL1 | |
| SCHEMBL18877419 | 0.76 | SMN1; SMN2 (0.41) | SLC1A2SMN1; SMN2TSHRHTTKMT2A | |
| SCHEMBL10037495 | 0.75 | SLC1A2 (0.42) | SLC1A2SMN1; SMN2TSHRHTTL3MBTL1 | |
| Trifluoroacetic Acid SCHEMBL18261734 | 0.72 | AKT1 (0.38) | SLC1A2SMN1; SMN2TSHRHTTL3MBTL1 | |
| SCHEMBL9457039 | 0.72 | SLC1A2 (0.40) | SLC1A2SMN1; SMN2TSHRHTTL3MBTL1 | |
| SCHEMBL10037551 | 0.72 | POLB (0.38) | SLC1A2SMN1; SMN2HTTKMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124791-B2 | Active energy ray curable liquid composition and liquid cartridge | CANON KABUSHIKI KAISHA (JP) | 2012-02-28 | — | — | US | disclosed |
| US-20100094024-A1 | ACTIVE ENERGY RAY CURABLE LIQUID COMPOSITION AND LIQUID CARTRIDGE | CANON KABUSHIKI KAISHA (JP) | 2010-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100094024-A1 | ACTIVE ENERGY RAY CURABLE LIQUID COMPOSITION AND LIQUID CARTRIDGE | C9, MLX, CHRM1 | SLC1A2 933/4885SMN1; SMN2 808/4885TSHR 2790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.